Pharmaron Beijing Extends Research Contract With Newbay Technology Through 2029
Pharmaron Beijing extended its research contract with Newbay Technology by three years, through the end of 2029.
Related stories
Ingersoll Rand Reports Quarterly Results Through September 30
Ingersoll Rand reported results for the quarter ended September 30; the supplied text contains no financial figures.
M impact | EQUITY | Oct 29, 2026, 10:33 PM UTC
Grid Dynamics Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Oct 29, 2026, 10:33 PM UTC
Forrester Research Reports Quarterly Results
Forrester Research Inc reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 10:33 PM UTC
Simble Solutions requests trading halt ahead of capital-raise announcement
Simble Solutions requested a trading halt pending an announcement on a material capital raise.
M impact | EQUITY | Oct 29, 2026, 10:33 PM UTC
Black Diamond Group Reports Q3 Pretax Profit of CAD 13.8 Million
M impact | EQUITY | Oct 29, 2026, 10:32 PM UTC
Supernus Pharmaceuticals reports quarterly results
Supernus Pharmaceuticals reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 10:32 PM UTC